Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Organic Anion Transporter Gene Variants Associated with Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Clinical Pharmacology & Therapeutics Date published:

  • Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy

    European Heart Journal Date published:

  • CANAGLIFLOZIN, MENTAL HEALTH ADVERSE EVENTS, AND DIABETES: EXPLORATORY ANALYSIS OF THE CREDENCE TRIAL AND CANVAS PROGRAM

    Diabetes, Obesity and Metabolism Date published:

  • Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

    Journal of the American Heart Association Date published:

  • Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)

    Diabetes Care Date published:

  • 862-P: Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial

    Diabetes Date published:

  • 747-P: Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes Trial

    Diabetes Date published:

  • Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial

    Journal of Diabetes Research Date published:

  • Canagliflozin and Atrial Fibrillation in Type 2 Diabetes Mellitus: A secondary analysis from the CANVAS Program and CREDENCE trials and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

    JAMA Date published:

  • Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

    JACC: Heart Failure Date published:

  • Platform Clinical Trials Within Nephrology-Interpreting the Evidence

    American Journal of Kidney Diseases Date published:

  • FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease

    Nephrology Dialysis Transplantation Date published:

  • A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

    Frontiers in Cardiovascular Medicine Date published:

  • Sodium-glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 diabetes: A Meta-analysis of Individual Participant Data from Randomized Controlled Trials

    Circulation Date published: